---
155: NCI Yeast Anticancer Drug Screen. Data for the rad50 strain
157: NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain
161: NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain
165: NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain
167: NCI Yeast Anticancer Drug Screen. Data for the bub3 strain
175: NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain
248: NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal)
  in B6D2F1 (BDF1) mice
256: NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal)
  in CD2F1 (CDF1) mice
330: NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal)
  in CD2F1 (CDF1) mice
421: Cell Viability - BJ
426: Cell Viability - Jurkat
427: Cell Viability - Hek293
433: Cell Viability - HepG2
434: Cell Viability - MRC5
435: Cell Viability - SK-N-SH
445: IkB Signaling
530: JNK3 AlphaScreen Assay
540: Cell Viability - N2a
541: Cell Viability - NIH 3T3
542: Cell Viability - HUV-EC-C
543: Cell Viability - H-4-II-E
544: Cell Viability - SH-SY5Y
545: Cell Viability - Renal Proximal Tubule
546: Cell Viability - Mesenchymal
584: Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent)
585: Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent)
595: qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction
596: qHTS Assay for Tau Filament Binding
603: qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System
605: qHTS Assay for Inhibitors of YjeE
654: Cellular Toxicity (caspase-3) HepG2
655: Cellular Toxicity (caspase-3) Jurkat
656: Cellular Toxicity (caspase-3) HUV-EC-C
657: Cellular Toxicity (caspase-3) SHSY5Y
658: Cellular Toxicity (caspase-3) BJ
659: Cellular Toxicity (caspase-3) MRC-5
660: Cellular Toxicity (caspase-3) Mesangial
661: Cellular Toxicity (caspase-3) SK-N-SH
662: Cell signaling CRE-BLA (Fsk stim)
663: Cellular Toxicity (caspase-3) H-4-II-E
664: Cellular Toxicity (caspase-3) Hek293
665: Cellular Toxicity (caspase-3) N2a
666: Cellular Toxicity (caspase-3) NIH 3T3
667: Cellular Toxicity (caspase-3) Renal Proximal Tubule
875: qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore)
880: qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore)
881: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2)
884: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4
885: qHTS Assay for Activators of Cytochrome P450 3A4
886: qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type
  II)
887: qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase)
889: qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7
892: qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore)
893: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase
  4
894: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)
900: qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1
902: 'qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations:
  Cytotoxicity of p53ts Cells at the Nonpermissive Temperature'
912: qHTS Assay for Anthrax Lethal Toxin Internalization
921: Cell Viability - LYMP2-001
923: 'qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic
  Profiling in AFC Spectral Region'
924: 'qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations:
  Cytotoxicity of p53ts Cells at the Permissive Temperature'
925: qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing
926: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor
938: 'qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators
  of Intracellular cAMP Concentrations in Parental HEK 293'
946: MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells
947: MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells
948: Cell Viability - LYMP1-002 - Assay at 16 hr
955: MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells
960: MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells
961: MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells
962: MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells
963: Cell Viability - LYMP1-003 - Assay at 24 hr
964: Cell Viability - LYMP1-003 - Assay at 40 hr
965: Cell Viability - LYMP2-003
966: Cell Viability - LYMP2-004
967: Cell Viability - LYMP2-005
968: Cell Viability - LYMP2-009
969: Cell Viability - LYMP2-011
970: Cell Viability - LYMP2-013
971: Cell Viability - LYMP2-015
972: Cell Viability - LYMP2-017
973: Cell Viability - LYMP2-019
974: Cell Viability - LYMP2-021
975: Cell Viability - LYMP2-023
976: Cell Viability - LYMP2-025
977: Cell Viability - LYMP2-002
978: Cell Viability - LYMP2-006
979: Cell Viability - LYMP2-007
980: Cell Viability - LYMP2-008
981: Cell Viability - LYMP2-010
982: Cell Viability - LYMP2-012
983: Cell Viability - LYMP2-014
984: Cell Viability - LYMP2-016
985: Cell Viability - LYMP2-018
986: Cell Viability - LYMP2-020
987: Cell Viability - LYMP2-022
988: Cell Viability - LYMP2-024
989: Cell Viability - LYMP2-026
993: Cell Viability - LYMP1-002 - Assay at 24 hr
994: Cell Viability - LYMP1-002 - Assay at 40 hr
995: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening
  Assay
1030: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1)
1188: DSSTox (EPAFHM) EPA Fathead Minnow Acute Toxicity
1189: DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results
1194: DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity
1199: DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results
1205: DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results
1208: DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results
1452: qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase)
1457: 'qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation
  with Lithium'
1458: qHTS Assay for Enhancers of SMN2 Splice Variant Expression
1469: qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid
  Receptor Coregulator 2
1471: 'qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington:
  Cytoprotection (ATP)'
1476: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent)
1477: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1
  for the Treatment of Acute Myeloid Leukemia
1478: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent)
1479: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid
  Hormone Receptor and Steroid Receptor Coregulator 2
1688: 'qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington:
  Aggregate Formation (GFP)'
1766: 'qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related
  Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide'
1768: 'qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related
  Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide'
1948: qHTS Assay for Compounds that Induce Erasure of Genomic Imprints
1987: Fluorescence-based primary biochemical high throughput screening assay to identify
  inhibitors of Protein Phosphatase 5 (PP5).
2016: Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_
  MEP2_MLPCN.
2023: Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_
  LAP4_MLPCN.
2025: Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_
  RPL19A_MLPCN.
2029: Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_
  CIT2_MLPCN.
2052: HTS for developing T Cell Immune Modulators
2057: Fluorescence polarization-based primary biochemical high throughput screening
  assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions
  with BIM-BH3 peptide.
2062: Ligands of bioamine (Class A) GPCRs
2063: Ligands of peptide (Class A) GPCRs
2066: Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_
  AGP1_MLPCN.
2099: Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity
2101: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential
  Chaperone Treatment of Gaucher Disease
2107: qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen
  Homogenate
2112: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen
  Homogenate
2120: qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response
2129: Primary biochemical high throughput screening assay to identify inhibitors of
  BCL2-related protein, long isoform (BCLXL).
2130: Fluorescence polarization-based primary biochemical high throughput screening
  assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).
2174: 'Counterscreen for PME1 inhibitors: fluorescence polarization-based primary
  biochemical high throughput screening assay to identify inhibitors of lysophospholipase
  1 (LYPLA1).'
2177: 'Counterscreen for PME1 inhibitors: fluorescence polarization-based primary
  biochemical high throughput screening assay to identify inhibitors of lysophospholipase
  2 (LYPLA2).'
2234: 'Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical
  high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded
  protein, ZTA.'
2235: 'Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput
  primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).'
2280: Fluorescence polarization-based primary biochemical high throughput screening
  assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.
2300: TR-FRET-based primary biochemical high throughput screening assay to identify
  agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).
2380: uHTS identification of small molecules that induce b-cell replication in the
  MIN-6 cell line
2391: A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory
  syncytial virus (RSV)
2435: Fluorescence-based primary cell-based high throughput screening assay to identify
  agonists of the Oxytocin Receptor (OXTR).
2445: Fluorescence-based primary cell-based high throughput screening assay to identify
  potentiators of Oxytocin Receptor (OXTR)
2462: Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.
2517: qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1
  (APE1)
2520: uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent
  beta-arrestin assay
2521: uHTS identification of small molecule antagonists of the APJ  receptor  via
  a luminescent beta-arrestin assay
2524: uHTS Luminescent assay for identification of activators of human intestinal
  alkaline phosphatase
2528: qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM)
2540: HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease
  8 (SENP8)
2544: uHTS Luminescent assay for identification of inhibitors of human intestinal
  alkaline phosphatase
2546: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity
2549: qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)
2551: qHTS for inhibitors of ROR gamma transcriptional activity
2557: HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library
2599: uHTS Luminescent assay for identification of inhibitors of Sentrin-specific
  protease 6 (SENP6)
2606: Fluorescence polarization-based primary biochemical high throughput screening
  assay to identify inhibitors of the membrane-associated serine protease Rv3671c
  in M.tuberculosis
2629: Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors
  of the LANA Histone H2A/H2B Interaction
2650: Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3
  alpha
2661: Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase
  33  Activity
2662: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA
  interaction
2676: qHTS Assay for Agonists of the Relaxin Receptor RXFP1
2685: qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells
2690: A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide
2716: Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation
  Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301
2717: Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells
2718: Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone
  Deacetylase 3
2751: Fluorescence polarization-based primary biochemical high throughput screening
  assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL)
2796: Luminescence-based primary cell-based high throughput screening assay to identify
  activators of the Aryl Hydrocarbon Receptor (AHR)
2797: 'Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary
  cell-based high throughput assay to identify agonists of the vasopressin 1 receptor
  (V1R)'
2805: uHTS Luminescent assay for identification of activators of mouse intestinal
  alkaline phosphatase
2806: uHTS Luminescent assay for identification of inhibitors of mouse intestinal
  alkaline phosphatase
2825: uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast
39219: Apparent Michaelis constant (Km) against Arylsulfotransferase (AST IV)
241172: Inhibitory concentration against human cytochrome P450 2A6
241174: Inhibitory concentration against mouse cytochrome P450 2A5
241334: Inhibitory concentration against recombinant human cytochrome P450 1A2
376049: Antifungal activity against Candida albicans ATCC 10231 by agar dilution method
376050: Antifungal activity against Saccharomyces cerevisiae ATCC 9763 by agar dilution
  method
376051: Antifungal activity against Cryptococcus neoformans ATCC 32264 by agar dilution
  method
376052: Antifungal activity against Aspergillus flavus ATCC 9170 by agar dilution
  method
376053: Antifungal activity against Aspergillus fumigatus ATCC 26934 by agar dilution
  method
376054: Antifungal activity against Aspergillus niger ATCC 9029 by agar dilution method
420670: Inhibition of mouse CYP2A5
420671: Inhibition of human CYP2A6
434955: Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis
  to Beta-lactam Antibiotics
434962: Fluorescence polarization-based cell-based primary high throughput screening
  assay to identify inhibitors of insulin-degrading enzyme (IDE)
434973: uHTS Luminescent assay for identification of inhibitors of Sentrin-specific
  protease 7 (SENP7)
434989: Fluorescence-based cell-based primary high throughput screening assay to identify
  antagonists of the orexin 1 receptor (OX1R; HCRTR1)
435003: uHTS luminescence assay for the identification of chemical inhibitors of T-cell
  specific antigen receptor-induced NF-kB activation
435005: Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.
435022: uHTS luminescence assay for the identification of chemical inhibitors of B-cell
  specific antigen receptor-induced NF-kB activation
435030: Absorbance-based primary bacterial cell-based high throughput screening assay
  to identify inhibitors of AddAB recombination protein complex
449728: 'Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based
  high throughput screening assay to identify inhibitors of bacterial viability'
449762: High Throughput Screening Assay used to Identify Novel Compounds that Inhibit
  Mycobacterium Tuberculosis in 7H9 Media
449763: uHTS identification of small molecule activators of the apoptotic arm of the
  Unfolded Protein response via a luminescent-based reporter assay
463079: 'Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists:
  cell-based assay to identify antagonists of the parental CHO cell line'
463082: Fluorescence polarization-based primary biochemical high throughput screening
  assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase
  (pPAFAH)
463104: uHTS identification of small molecule activators of the adaptive arm of the
  Unfolded Protein response via a luminescent-based reporter assay
463141: Absorbance-based primary biochemical high throughput screening assay to identify
  activators of procaspase-3
463190: uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent
  assay
463195: uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent
  assay
463210: 'Counterscreen for procaspase-3 activators: absorbance-based primary biochemical
  high throughput screening assay to identify activators of procaspase-7'
463212: uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent
  assay
463254: qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2
  as the Reporter
485270: FRET-based cell-based primary high throughput screening assay to identify
  antagonists of the orexin 1 receptor (OX1R; HCRTR1)
485272: Fluorescence polarization-based primary biochemical high throughput screening
  assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS)
485273: uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay
485275: Phenotypic HTS multiplex for antifungal efflux pump inhibitors
485290: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1)
485294: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent)
485297: qHTS Assay for Rab9 Promoter Activators
485298: qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators
  of Mitochondrial Fusion
485313: qHTS Assay for NPC1 Promoter Activators
485317: HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide
  production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS
485341: qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent)
485344: 'HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary
  Screen for Antagonists'
485346: uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent
  format.
485347: 'HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor:
  Primary Screen for Potentiators'
485349: qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia
485353: qHTS of Yeast-based Assay for SARS-CoV PLP
485358: 'HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary
  Screen for Agonists'
485360: qHTS Assay for the Inhibitors of L3MBTL1
485364: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins
485367: qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase
488837: qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2
488839: Development of CDK5 inhibitors   Measured in Biochemical System Using Plate
  Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity
488847: RNA aptamer-based HTS for inhibitors of GRK2
488862: Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using
  Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity
488890: Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium
  tuberculosis
488895: High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism
  System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity
488896: HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in
  Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity
488899: MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity
488965: Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa
  PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination
  - 2091-01_Inhibitor_SinglePoint_HTS_Activity
488966: Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis
489030: uHTS Fluorescent assay for identification of inhibitors of Apaf-1
489031: uHTS Fluorescent assay for identification of activators of Apaf-1
492947: qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor
492953: Fluorescence polarization-based primary biochemical high throughput screening
  assay to identify inhibitors of human platelet-activating factor acetylhydrolase
  1b, catalytic subunit 2 (PAFAH1B2)
492956: Fluorescence polarization-based primary biochemical high throughput screening
  assay to identify inhibitors of human platelet activating factor acetylhydrolase
  2 (PAFAH2)
492961: 'qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation'
492972: Fluorescence polarization-based primary biochemical high throughput screening
  assay to identify inhibitors of human platelet-activating factor acetylhydrolase
  1B, catalytic subunit 3 (PAFAH1B3)
493005: qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of
  PTAP/TSG101
493008: Fluorescence-based biochemical primary high throughput screening assay to
  identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments
  (RTF)
493011: uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based
  single-stranded DNA deaminase assay
493012: uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based
  single-stranded DNA deaminase assay
493014: qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling
493036: Image-Based HTS for Selective Agonists for NTR1
493056: 'qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor:
  Primary Screen for Enhancers'
493084: 'qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor:
  Primary Screen for Agonists.'
493087: Fluorescence polarization-based cell-based primary high throughput screening
  assay to identify activators of insulin-degrading enzyme (IDE)
493091: uHTS Colorimetric assay for identification of inhibitors of Scp-1
493098: uHTS identification of small molecule antagonists of the CCR6 receptor via
  a luminescent beta-arrestin assay
493131: Activator for delta FosB/delta FosB homodimer Measured in Biochemical System
  Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity
493160: uHTS Fluorescent assay for identification of inhibitors of hexokinase domain
  containing  I (HKDC1)
493187: uHTS Fluorescent assay for identification of activators of hexokinase domain
  containing  I (HKDC1)
493244: Fluorescence-based biochemical primary high throughput screening assay to
  identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments
  (RTF)
504326: Luminescence-based cell-based primary high throughput screening assay to identify
  agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors
504327: qHTS Assay for Inhibitors of GCN5L2
504329: Discovery of Small Molecule Probes for H1N1 Influenza NS1A
504332: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a
504333: qHTS Assay for Inhibitors of BAZ2B
504339: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain
504357: Luminescence-based cell-based primary high throughput screening assay to identify
  inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid
  receptors
504406: Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM)
  enzyme - High throughput screening using Fluorescent polarization assay Measured
  in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6
504411: Fluorescence-based primary biochemical high throughput screening assay to
  identify inhibitors of human diacylglycerol lipase, beta (DAGLB)
504414: Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System
  Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity
504423: C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity
504444: Nrf2 qHTS screen for inhibitors
504454: HTS for Beta-2AR agonists via FAP method
504462: uHTS fluorescent assay for identification of inhibitors of ATG4B
504466: qHTS screen for small molecules that induce genotoxicity in human embryonic
  kidney (HEK293T) cells expressing luciferase-tagged ELG1
504467: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in
  human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1
504490: Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That
  Mediate GPCR Degradation and Recycling
504523: Fluorescence polarization to screen for inhibitors that disrupt the protein-protein
  interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate
  Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity
504558: Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured
  in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity
504577: HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using
  pHLuorin
504582: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival
  of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System
  Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity
504621: Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate
  Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2
504634: 'Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based
  cell-based full-deck high throughput screening assay to identify inverse agonists
  of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A)'
504648: 'Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity'
504651: 'Potentiators of Human D1 Dopamine Receptor: qHTS'
504660: 'Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS'
504690: uHTS identification of small molecule inhibitors of Plasmodium falciparum
  Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay
504692: 'Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based
  cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine
  (serotonin) 5A receptor (HTR5A)'
504700: Fluorescence polarization-based biochemical primary high throughput screening
  assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex
504706: qHTS assay for re-activators of p53 using a Luc reporter
504707: Fluorescence polarization-based biochemical primary high throughput screening
  assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex
504720: uHTS identification of MazEF TA System activators  via a fluorescence-based
  single-stranded RNase assay
504734: Fluorescence-based cell-based primary high throughput screening assay to identify
  inhibitors of TLR9-MyD88 binding.
504749: qHTS profiling for inhibitors of Plasmodium falciparum proliferation
504766: Luminescence-based primary cell-based high throughput screening assay to identify
  inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1;
  NR0B1)
504775: HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in
  Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity
504803: Fluorescence polarization-based primary biochemical high throughput screening
  assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1)
504810: 'Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign'
504812: 'Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign'
504832: Primary qHTS for delayed death inhibitors of the malarial parasite plastid,
  48 hour incubation
504834: Primary qHTS for delayed death inhibitors of the malarial parasite plastid,
  96 hour incubation
504842: 'Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn):
  qHTS'
504845: 'Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS'
504847: 'Inhibitors of the vitamin D receptor (VDR): qHTS'
504865: 'Inhibitors of USP1/UAF1: Pilot qHTS'
504884: Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured
  in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity
504891: qHTS Assay to Find Inhibitors of Pin1
504894: 'Activators of T cell receptors: qHTS campaign'
504937: 'Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS'
512726: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2433) mutant
  assessed as number of extra cells in anterior pharynx L3 and L4 larvae at 200 mM
  dissolved in soybean oil
512727: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2438) mutant
  assessed as increase in number of extra cells in anterior pharynx at 50 uM dissolved
  in water
512728: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2438) mutant
  assessed as increase in number of extra cells in anterior pharynx at 75 uM dissolved
  in water
512729: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2438) mutant
  assessed as increase in number of extra cells in anterior pharynx at 100 uM dissolved
  in water
512730: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2438) mutant
  assessed as increase in number of extra cells in anterior pharynx at 125 uM dissolved
  in water
512731: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2438) mutant
  assessed as increase in number of extra cells in anterior pharynx at 150 uM dissolved
  in water
512732: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2438) mutant
  assessed as increase in number of extra cells in anterior pharynx kept in drug exposed
  air tight plastic storage box at 0.06 g/L in air
512733: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2438) mutant
  assessed as increase in number of extra cells in anterior pharynx kept in drug exposed
  air tight plastic storage box at 0.6 g/L in air
512734: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2438) mutant
  assessed as increase in number of extra cells kept in anterior pharynx in gaseous
  compound exposed air tight plastic storage box at 4 uM
512735: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2438) mutant
  assessed as increase in number of extra cells in anterior pharynx at 100 mM dissolved
  in soybean oil
512737: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2438) mutant
  assessed as number of extra cells in anterior pharynx L3 and L4 larvae at 200 mM
  dissolved in soybean oil
512738: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2438) G474R mutant
  assessed as number of extra cells in anterior pharynx L3 and L4 larvae at 200 mM
  dissolved in soybean oil
512739: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2447) S446L mutant
  assessed as number of extra cells in anterior pharynx L3 and L4 larvae at 200 mM
  dissolved in soybean oil
512740: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2436) L269 mutant
  assessed as number of extra cells in anterior pharynx L3 and L4 larvae at 200 mM
  dissolved in soybean oil
512741: Antiapoptotic activity against Caenorhabditis elegans ced-4(n2273) mutant
  assessed as number of extra cells in anterior pharynx L3 and L4 larvae at 200 mM
  dissolved in soybean oil
512742: Antiapoptotic activity against Caenorhabditis elegans ced-8(n1891) mutant
  assessed as number of extra cells in anterior pharynx L3 and L4 larvae at 200 mM
  dissolved in soybean oil
512743: Antiapoptotic activity against Caenorhabditis elegans ced-9(n1950) mutant
  assessed as number of extra cells in anterior pharynx L3 and L4 larvae at 200 mM
  dissolved in soybean oil
513046: Inhibition of Caenorhabditis elegans CED-3-mediated apoptosis assessed as
  [35]S methionine labeled CED-9 cleavage product at 100 uM after 2 hrs by fluorescence
  assay
513047: Inhibition of human caspase-3-mediated apoptosis assessed as appearance of
  [35]S methionine-labeled PARP cleavage product at 100 uM after 2 hrs by fluorescence
  assay
513048: Inhibition of human caspase-3-mediated apoptosis assessed as Ac-DEVD-7-amino-4-methylcoumarin
  cleavage product at 100 uM by fluorescence assay
513049: Antiapoptotic activity against wild-type Caenorhabditis elegans assessed as
  reduction in number of cell cropses at comma stage of embryo at 200 uM dissolved
  in soybean oil
513050: Antiapoptotic activity against wild-type Caenorhabditis elegans assessed as
  reduction in number of cell cropses at 1.5 fold stage of embryo at 200 uM dissolved
  in soybean oil
513051: Antiapoptotic activity against wild-type Caenorhabditis elegans assessed as
  reduction in number of cell cropses at 2-fold stage of embryo at 200 uM dissolved
  in soybean oil
513052: Antiapoptotic activity against wild-type Caenorhabditis elegans assessed as
  reduction in number of cell cropses at 4-fold stage of embryo at 200 uM dissolved
  in soybean oil
513053: Antiapoptotic activity against wild-type Caenorhabditis elegans assessed as
  reduction in number of cell cropses at comma stage of embryo at 250 uM dissolved
  in soybean oil
513054: Antiapoptotic activity against wild-type Caenorhabditis elegans assessed as
  reduction in number of cell cropses at 1.5 fold stage of embryo at 250 uM dissolved
  in soybean oil
513055: Antiapoptotic activity against wild-type Caenorhabditis elegans assessed as
  reduction in number of cell cropses at 2-fold stage of embryo at 250 uM dissolved
  in soybean oil
513056: Antiapoptotic activity against wild-type Caenorhabditis elegans assessed as
  reduction in number of cell cropses at 4-fold stage of embryo at 250 uM dissolved
  in soybean oil
513057: Antiapoptotic activity against Caenorhabditis elegans engulfment-deffective
  ced-1(e1735) mutant assessed as reduction in number of cell cropses at comma stage
  of embryo at 200 uM dissolved in soybean oil
513058: Antiapoptotic activity against Caenorhabditis elegans engulfment-deffective
  ced-1(e1735) mutant assessed as reduction in number of cell cropses at 1.5-fold
  stage of embryo at 200 uM dissolved in soybean oil
513059: Antiapoptotic activity against Caenorhabditis elegans engulfment-deffective
  ced-1(e1735) mutant assessed as reduction in number of cell cropses at 2-fold stage
  of embryo at 200 uM dissolved in soybean oil
513060: Antiapoptotic activity against Caenorhabditis elegans engulfment-deffective
  ced-1(e1735) mutant assessed as reduction in number of cell cropses at comma 4-fold
  of embryo at 200 uM dissolved in soybean oil
513061: Antiapoptotic activity against Caenorhabditis elegans engulfment-deffective
  ced-1(e1735) mutant assessed as reduction in number of cell cropses at comma stage
  of embryo at 250 uM dissolved in soybean oil
513062: Antiapoptotic activity against Caenorhabditis elegans engulfment-deffective
  ced-1(e1735) mutant assessed as reduction in number of cell cropses at 1.5-fold
  stage of embryo at 250 uM dissolved in soybean oil
513063: Antiapoptotic activity against Caenorhabditis elegans engulfment-deffective
  ced-1(e1735) mutant assessed as reduction in number of cell cropses at 2-fold stage
  of embryo at 250 uM dissolved in soybean oil
513064: Antiapoptotic activity against Caenorhabditis elegans engulfment-deffective
  ced-1(e1735) mutant assessed as reduction in number of cell cropses at comma 4-fold
  of embryo at 250 uM dissolved in soybean oil
513065: Antiapoptotic activity against hermaphroditic wild type Caenorhabditis elegans
  carrying smls26 transgene assessed as inhibition of male-specific CEM neurons death
  at 200 mM after 2 hrs
513066: Antiapoptotic activity against hermaphroditic Caenorhabditis elegans ced-3(n2438)
  mutant carrying smls26 transgene assessed as inhibition of male-specific CEM neurons
  death at 200 mM after 2 hrs
513067: Antiapoptotic activity against hermaphroditic Caenorhabditis elegans ced-3(n2433)
  mutant carrying smls26 transgene assessed as inhibition of male-specific CEM neurons
  death at 200 mM after 2 hrs
513068: Antiapoptotic activity against hermaphroditic wild type Caenorhabditis elegans
  carrying smls26 transgene assessed as inhibition of male-specific CEM neurons death
  at 250 mM after 2 hrs
513069: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2438) mutant
  carrying smls26 transgene assessed as survival of CEM neurons at 250 mM after 2
  hrs
513070: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2433) mutant
  carrying smls26 transgene assessed as survival of CEM neurons at 250 mM after 2
  hrs
513071: Antiapoptotic activity against wild type Caenorhabditis elegans carrying nis96
  transgene assessed as number of extra VC- cells in postembryonic stage at 200 mM
  after 2 hrs
513072: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2438) mutant
  carrying nis96 transgene assessed as number of extra VC- cells in postembryonic
  stage at 200 mM after 2 hrs
513073: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2433) mutant
  carrying nis96 transgene assessed as number of extra VC- cells in postembryonic
  stage at 200 mM after 2 hrs
513074: Antiapoptotic activity against Caenorhabditis elegans carrying nis96 transgene
  assessed as number of extra VC- cells in postembryonic stage at 250 mM after 2 hrs
513075: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2438) mutant
  carrying nis96 transgene assessed as number of extra VC- cells in postembryonic
  stage at 250 mM after 2 hrs
513076: Antiapoptotic activity against Caenorhabditis elegans ced-3(n2433) mutant
  carrying nis96 transgene assessed as number of extra VC- cells in postembryonic
  stage at 250 mM after 2 hrs
513077: Suppression of activated CED-3-induced apoptosis expressed in Caenorhabditis
  elegans ced-1(e1735) mutant assessed as number of cell corpses in 4-fold stage of
  transgenic line-1 embryo in absence of CED-4
513078: Suppression of activated CED-3-induced apoptosis expressed in Caenorhabditis
  elegans ced-4(n1162) mutant assessed as number of cell corpses in 4-fold stage of
  transgenic line-1 embryo in absence of CED-4
513079: Suppression of activated CED-3-induced apoptosis expressed in Caenorhabditis
  elegans ced-1(e1735) mutant assessed as number of cell corpses in 4-fold stage of
  transgenic line-2 embryo in absence of CED-4
513080: Suppression of activated CED-3-induced apoptosis expressed in Caenorhabditis
  elegans ced-4(n1162) mutant assessed as number of cell corpses in 4-fold stage of
  transgenic line-2 embryo in absence of CED-4
513081: Suppression of activated CED-3-induced apoptosis expressed in Caenorhabditis
  elegans ced-1(e1735) mutant assessed as number of cell corpses in 4-fold stage of
  transgenic line-3 embryo in absence of CED-4
513082: Suppression of activated CED-3-induced apoptosis expressed in Caenorhabditis
  elegans ced-4(n1162) mutant assessed as number of cell corpses in 4-fold stage of
  transgenic line-3 embryo in absence of CED-4
513083: Suppression of activated CED-3-induced apoptosis expressed in Caenorhabditis
  elegans ced-1(e1735) mutant assessed as number of cell corpses in 4-fold stage of
  (smls111) transgenic embryo in absence of CED-4
513084: Suppression of activated CED-3-induced apoptosis expressed in Caenorhabditis
  elegans ced-4(n1162) mutant assessed as number of cell corpses in 4-fold stage of
  (smls111) transgenic embryo in absence of CED-4
540253: qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta
  cargo) - Importin beta complex dissociation
540263: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin
  beta complex formation
540267: 'Small Molecules that selectively kill Giardia lamblia: qHTS'
540275: HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1
540277: HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor
  1
540295: 'TRFRET-based cell-based primary high throughput screening assay to identify
  biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R'
540303: qHTS for Inhibitors of Cell Surface uPA Generation
540308: 'Luminescence-based cell-based primary high throughput screening assay to
  identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R'
540317: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone
  Tails
540336: Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity
540364: Luminescence-based cell-based primary high throughput screening assay to identify
  activators of the GAA850 frataxin (FXN) promoter
588334: MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity
588335: 'Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA)
  of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate
  Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay
  artifacts'
588342: qHTS profiling assay for firefly luciferase inhibitor/activator using purifed
  enzyme and Km concentrations of substrates (counterscreen for miR-21 project)
588352: Luminescence-based cell-based primary high throughput screening assay to identify
  inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3)
588354: Luminescence-based cell-based primary high throughput screening assay to identify
  inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1)
588358: HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies
588405: HTS Assay for Peg3 Promoter Inhibitors
588413: uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay
588436: 'Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers
  using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using
  Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity'
588453: 'qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase
  1 (TrxR1): qHTS'
588456: 'qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase
  1 (TrxR1): qHTS'
588458: uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon
  assay
588473: uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor
  complex
588475: uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor
  complex
588478: A screen for small molecule inhibitors of the human deubiquitinating enzyme,
  UCH37
588489: uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by
  fluoresence polarization assay
588492: uHTS identification of small molecule modulators of myocardial damage
588493: uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay
588497: High-throughput multiplex microsphere screening for inhibitors of toxin protease,
  specifically Botulinum neurotoxin light chain F protease, MLPCN compound set
588499: High-throughput multiplex microsphere screening for inhibitors of toxin protease,
  specifically Botulinum neurotoxin light chain A protease, MLPCN compound set
588501: High-throughput multiplex microsphere screening for inhibitors of toxin protease,
  specifically Lethal Factor Protease, MLPCN compound set
588513: qHTS assay for small molecule antagonists of estrogen receptor alpha signaling
588514: qHTS assay for small molecule agonists of estrogen receptor alpha signaling
588515: qHTS assay for small molecule agonists of androgen receptor signaling
588516: qHTS assay for small molecule antagonists of androgen receptor signaling
588526: qHTS assay for small molecule antagonists of farnesoid X receptor signaling
588527: qHTS assay for small molecule agonists of farnesoid X receptor signaling
588532: qHTS assay for small molecule agonists of glucocorticoid receptor signaling
588533: qHTS assay for small molecule antagonists of glucocorticoid receptor signaling
588534: qHTS assay for small molecule agonists of peroxisome proliferator-activated
  receptor delta signaling
588535: qHTS assay for small molecule antagonists of peroxisome proliferator-activated
  receptor delta signaling
588536: qHTS assay for small molecule agonists of peroxisome proliferator-activated
  receptor gamma signaling
588537: qHTS assay for small molecule antagonists of peroxisome proliferator-activated
  receptor gamma signaling
588541: qHTS assay for small molecule antagonists of vitamin D receptor signaling
588543: qHTS assay for small molecule agonists of vitamin D receptor signaling
588544: qHTS assay for small molecule agonists of retinoid X receptor alpha signaling
588545: qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling
588546: qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling
588547: qHTS assay for small molecule antagonists of thyroid hormone receptor beta
  signaling
588549: Fluorescence polarization to screen for inhibitor that competite the binding
  of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity
588579: qHTS for Inhibitors of Polymerase Kappa
588590: qHTS for Inhibitors of Polymerase Iota
588591: qHTS for Inhibitors of Polymerase Eta
588621: uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase
  via a fluorescence intensity assay
588664: TRFRET-based biochemical primary high throughput screening assay to identify
  inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and
  the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)
588674: 'Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured
  in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2'
588689: Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition
588692: Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation
  Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2
588726: Fluorescence-based biochemical primary high throughput screening assay to
  identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis
588727: A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83
588795: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).
588814: Fluorescence-based cell-based primary high throughput screening assay to identify
  agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)
588819: Fluorescence-based cell-based primary high throughput screening assay to identify
  positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).
588832: Hedgehog Measured in Biochemical System Using Plate Reader - 2070-01_Inhibitor_SinglePoint_HTS_Activity
588834: qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity
588850: uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence
  assay
588852: Fluorescence-based cell-based primary high throughput screening assay to identify
  antagonists of the human M1 muscarinic receptor (CHRM1)
588855: qHTS for Inhibitors of TGF-b
588856: 'qHTS for Inhibitors of TGF-b: Cytotox Counterscreen'
602123: Fluorescence polarization-based primary biochemical high throughput screening
  assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease
  La (eLon)
602141: uHTS determination of small molecule cytotoxicity in a fluorescence assay
  to identify cystic fibrosis induced NFkb Inhibitors
602162: Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for
  MLPCN Compound Set
602163: Absorbance-based biochemical primary high throughput screening assay to identify
  activators of Methionine sulfoxide reductase A (MsrA)
602179: 'qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS'
602229: Luminescence-based cell-based high throughput primary screening assay to identify
  agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)
602233: qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase
602244: uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay
602247: 'Full deck counterscreen for positive allosteric modulators (PAMs) of the
  human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput
  screening assay to identify nonselective activators and assay artifacts using the
  parental CHOK1 cell line'
602248: 'Full deck counterscreen for agonists of the human M1 muscarinic receptor
  (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify
  nonselective activators and assay artifacts using the parental CHOK1 cell line'
602250: 'Full deck counterscreen for antagonists of the human M1 muscarinic receptor
  (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify
  nonselective inhibitors and assay artifacts using the parental CHOK1 cell line'
602252: Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using
  Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity
602261: uHTS identification of small molecule inhibitors of  the thioesterase domain
  of fatty acid synthase via a fluorescence intensity assay
602274: uHTS luminescent assay for identification of compounds that enhance the survival
  of human induced pluripotent stem cells when cultured as single cells
602281: Luminescence-based biochemical primary high throughput screening assay to
  identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase
  domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)
602310: 'qHTS for Inhibitors of Vif-A3G Interactions: qHTS'
602313: 'qHTS for Inhibitors of Vif-A3F Interactions: qHTS'
602329: Identification of inhibitors of RAD54 Measured in Biochemical System Using
  Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity
602332: 'qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in
  Human Glioma: qHTS'
602340: HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12
  cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity
602342: Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate
  Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity
602346: Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging
  - 2108-01_Inhibitor_SinglePoint_HTS_Activity
602363: Whole cell Yeast HTS to identify compounds modulating the fidelity of the
  start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate
  Reader - 2155-01_Other_SinglePoint_HTS_Activity
602393: Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF)
  in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based
  System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity
602396: Luminescence-based cell-based primary high throughput screening assay to identify
  inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2)
602399: uHTS identification of inhibitors of NadD in a Colorimetric assay
602405: 'PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical
  System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity'
602410: Primary cell-based screen for identification of compounds that inhibit the
  two-pore domain potassium channel KCNK3
602429: uHTS identification of SUMO1-mediated protein-protein interactions
602438: uHTS identification of modulators of interaction between CendR and NRP-1 using
  Fluorescence Polarization assay
602440: uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of
  Inhibitors of Sentrin-Specific Protease 8 (SENP8)
602449: uHTS identification of small molecule inhibitors of the mitochondrial permeability
  transition pore via an absorbance assay
602481: Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System
  Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity
623877: Primary cell-based high-throughput screening for identification of compounds
  that activate/potentiate calcium-activated chloride channels (TMEM16A)
623901: Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate
  Reader - 2144-01_Activator_SinglePoint_HTS_Activity
624030: Biochemical firefly luciferase enzyme assay for NPC
624031: S16 Schwann cell viability assay (CellTiter-Glo assay)
624032: S16 Schwann cell PMP22 intronic element firefly luciferase assay
624037: Fluorescence-based cell-based primary high throughput screening assay to identify
  agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)
624038: Fluorescence-based cell-based primary high throughput screening assay to identify
  positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic
  5 (CHRM5)
624040: Fluorescence-based cell-based primary high throughput screening assay to identify
  antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)
624044: S16 Schwann cell PMP22 intronic element beta-lactamase assay
624125: Fluorescence-based cell-based primary high throughput screening assay to identify
  antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)
624126: Fluorescence-based cell-based primary high throughput screening assay to identify
  positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic
  4 (CHRM4)
624127: Fluorescence-based cell-based primary high throughput screening assay to identify
  agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)
624168: uHTS identification of small molecule activators of alpha dystroglycan glycosylation
624169: Luminescence-based cell-based primary high throughput screening assay to identify
  agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A)
624170: qHTS for Inhibitors of Glutaminase (GLS)
624171: qHTS of Nrf2 Activators
624172: qHTS of GLP-1 Receptor Agonists
624173: qHTS of Trypanosoma Brucei Inhibitors
624202: qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression
624204: uHTS identification of small molecule inhibitors of the catalytic domain of
  the SUMO protease, SENP1 in a FRET assay
624246: qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction
624256: HTS to identify compounds that promote myeloid differentiation with MLPCN
  compound set
624263: A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1
  Expression
624267: Fluorescence-based cell-based primary high throughput screening assay to identify
  inhibitors of the interaction of nucleotide-binding oligomerization domain containing
  2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2)
624268: Luminescence-based biochemical primary high throughput screening assay to
  identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS)
624288: 'qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous
  Dysplasia/McCune-Albright Syndrome: qHTS'
624296: A quantitative high throughput screen for small molecules that induce DNA
  re-replication in MCF 10a normal breast cells.
624297: A quantitative high throughput screen for small molecules that induce DNA
  re-replication in SW480 colon adenocarcinoma cells.
624304: uHTS identification of SKN-1 Inhibitors in a fluoresence assay
624330: Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein
  MgcRacGAP -  Primary and Confirmatory Screens
624352: uHTS identification of HIF-2a Inhibitors in a luminesence assay
624354: uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay
624377: Fluorescence polarization-based biochemical primary high throughput screening
  assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain
  1 (ASAP1)
624414: qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1)
624415: qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1
  (TRPML1)
624416: TRFRET-based biochemical primary high throughput screening assay to identify
  small molecules that bind to the HIV-1-gp120 binding antibody, PG9
624417: qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode)
624418: 'qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen'
624463: 'Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine
  Receptor: Antagonists'
624464: 'Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine
  Receptor: Potentiators'
624465: 'Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine
  Receptor: Agonists'
624466: Fluorescence-based cell-based primary high throughput screening assay to identify
  antagonists of the human trace amine associated receptor 1 (TAAR1)
624467: Fluorescence-based cell-based primary high throughput screening assay to identify
  agonists of the human trace amine associated receptor 1 (TAAR1)
624483: Counterscreen of compound fluorescence effects on High-throughput multiplex
  microsphere screening for inhibitors of toxin protease
651550: 'HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen'
651560: uHTS identification of small molecule inhibitors of Low Molecular Weight Protein
  Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay
651572: Fluorescence polarization-based biochemical primary high throughput screening
  assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein
  1 (ARFGAP1)
651602: Absorbance-based primary bacterial cell-based high throughput screening assay
  to identify inhibitors of RecBCD (with phage)
651631: qHTS assay for small molecule agonists of the p53 signaling pathway
651632: qHTS assay for small molecules that induce genotoxicity in human embryonic
  kidney cells expressing luciferase-tagged ATAD5
651633: qHTS assay for small molecule agonists of the p53 signaling pathway - cell
  viability
651634: qHTS assay for small molecules that induce genotoxicity in human embryonic
  kidney cells expressing luciferase-tagged ATAD5 - cell viability
651635: qHTS for Inhibitors of ATXN expression
651636: uHTS identification of small molecule antagonists of the EBI2 receptor via
  a luminescent beta-arrestin assay
651640: DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System
  Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity
651644: qHTS Assay for Inhibitors of the HIV-1 protein Vpr
651647: uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay
651654: HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK)
  release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity
651658: Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy
  Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity
651661: Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein
  EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader
  - 7014-01_Inhibitor_SinglePoint_HTS_Activity
651687: MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader -
  2139-01_Inhibitor_SinglePoint_HTS_Activity
651699: uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay
651702: Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with
  MLPCN Compound Library
651710: FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System
  Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2
651711: Turbidometric Biochemical  Primary HTS  to identify inhibitors of ERp5 Measured
  in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity
651718: Absorbance-based biochemical primary high throughput screening assay to identify
  inhibitors of Methionine sulfoxide reductase A (MsrA)
651719: Fluorescence-based cell-based primary high throughput screening assay to identify
  antagonists of the Galanin Receptor 3 (GalR3)
651723: MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader -
  2139-01_Activator_SinglePoint_HTS_Activity
651724: qHTS Assay for Inhibitors of the CtBP/E1A Interaction
651725: qHTS Assay for Inhibitors of the Six1/Eya2 Interaction
651741: qHTS assay for small molecule agonists of the antioxidant response element
  (ARE) signaling pathway
651743: qHTS assay for small molecule activators of the p53 signaling pathway
651749: qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB)
  signaling pathway
651751: qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR)
  signaling pathway
651754: qHTS assay for small molecule disruptors of the mitochondrial membrane potential
  - 1 hr assay
651755: qHTS assay for small molecule disruptors of the mitochondrial membrane potential
  - 5 hr assay
651757: qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha
  (TNF-alpha) secretion
651758: qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8)
  secretion
651768: qHTS for Inhibitors of WRN Helicase
651777: qHTS assay for environmental chemicals that activate the Aryl hydrocarbon
  Receptor (AhR) signaling pathway
651778: qHTS assay for small molecule agonists of the peroxisome proliferator-activated
  receptor alpha (PPARalpha) signaling pathway
651800: Fluorescence-based biochemical primary high throughput assay to identify inhibitors
  of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe
651802: qHTS assay for small molecule antagonists of the retinoid-related orphan receptor
  gamma (ROR-gamma) signaling pathway
651819: High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity
651820: qHTS Assay for Inhibitors of Hepatitis C Virus (HCV)
651821: Fluorescence-based biochemical primary high throughput screening assay to
  identify molecules that bind r(CAG) RNA repeats
651828: A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift
  Valley Fever Virus
651838: qHTS assay for identifying genotoxic compounds that show differential cytotoxicity
  against a panel of isogenic chicken DT40 cell lines with known DNA damage response
  pathways
651957: Luminescence-based cell-based primary high throughput screening assay to identify
  inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2)
651958: 'Fluorescence-based biochemical high throughput screening primary assay to
  identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor
  domain protease (vOTU): Pep-AMC substrate'
651965: qHTS Assay for Activators of ClpP
651999: uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation
  of Cullin-Ring Ligases, vis a fluorescence polarization assay
652010: 'Luminescence-based cell-based primary high throughput screening assay for
  inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1;
  NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1'
652017: Luminescence-based cell-based primary high throughput screening assay to identify
  activators of the function of SWI/SNF related, matrix associated, actin dependent
  regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)
652025: qHTS of IL-2 Activators
652039: Fluorescence Intensity-based biochemical primary high throughput screening
  assay to identify activators of kallikrein-7 (K7) zymogen
652048: 'qHTS of D3 Dopamine Receptor Agonist: qHTS'
652051: 'qHTS of D3 Dopamine Receptor Potentiators: qHTS'
652054: 'qHTS of D3 Dopamine Receptor Antagonist: qHTS'
652067: Luminescence-based cell-based primary high throughput screening assay to identify
  activators of the DAF-12 from the parasite H. contortus (hcDAF-12)
652104: qHTS of TDP-43 Inhibitors
652105: qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K)
652106: qHTS of alpha-syn Inhibitors
652126: Luminescence-based cell-based primary high throughput screening assay to identify
  activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12)
652162: 'C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured
  in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity'
652163: 'S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity'
652197: MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity
652257: Primary biochemical fluorescence polarization-based high throughput screening
  assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1)
686940: Luminescence-based cell-based primary high throughput screening assay to identify
  inhibitors of COUP-TFII (NR2F2)
686964: TRFRET-based biochemical primary high throughput screening assay to identify
  inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated
  oligonucleotide
686970: 'qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS
  for the HT-1080-NT fibrosarcoma cell line'
686971: 'qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS
  for the HT-1080-IDH1KD cell line'
686978: 'qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS
  in cells in absence of CPT'
686979: 'qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS
  in cells in presence of CPT'
686996: VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured
  in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2
687014: Luminescence-based cell-based primary high throughput screening assay to identify
  agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).
687016: 'Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2):
  TRFRET-based biochemical primary high throughput screening assay to identify inhibitors
  of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated
  oligonucleotide'
720504: 'qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary
  Screen'
720508: Fluorescence polarization-based biochemical primary high throughput screening
  assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7)
  to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )]
720509: Fluorescence polarization-based biochemical primary high throughput screening
  assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6)
  to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )]
720511: Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane
  Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial
  Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity
720516: 'qHTS assay for small molecules that induce genotoxicity in human embryonic
  kidney cells expressing luciferase-tagged ATAD5: Summary'
720532: qHTS for Inhibitors of binding or entry into cells for Marburg Virus
720533: qHTS for Inhibitors of binding or entry into cells for Lassa Virus
720542: 'qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug
  Lead: Primary Screen'
720543: Fluorescence polarization-based biochemical high throughput primary assay
  to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).
720551: 'qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS'
720552: 'qHTS assay for small molecule agonists of the p53 signaling pathway: Summary'
720553: 'qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS'
720579: 'qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter
  Primary qHTS'
720580: 'qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter
  Primary qHTS'
720582: QFRET-based biochemical primary high throughput screening assay to identify
  exosite inhibitors of ADAM10.
720596: TRFRET-based cell-based primary high throughput screening assay to identify
  inhibitors of cell surface Prion Protein (PRPC)
720634: qHTS assay for small molecule disruptors of the mitochondrial membrane potential
  - cell viability
720635: qHTS assay for small molecule disruptors of the mitochondrial membrane potential
720636: qHTS assay for small molecule agonists of the antioxidant response element
  (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity
720637: 'qHTS assay for small molecule disruptors of the mitochondrial membrane potential:
  Summary'
720647: Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected
  HEK293 cells Inhibition
720648: QFRET-based biochemical primary high throughput screening assay to identify
  exosite inhibitors of ADAM17.
720652: qHTS assay for small molecule antagonists of the retinoid-related orphan receptor
  gamma (ROR-gamma) signaling pathway - cell viability counter screen
720653: qHTS assay for small molecule agonists of the antioxidant response element
  (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell
  viability counter screen
720659: qHTS assay for small molecule activators of the human pregnane X receptor
  (PXR) signaling pathway
720674: qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2
  cells
720675: qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2
  cells
720678: qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293
  cells
720679: qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293
  cells
720680: qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293
  cells
720681: qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293
  cell free culture
720682: qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293
  cell free culture
720683: qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293
  cell free culture
720684: qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2
  cell free culture
720685: qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2
  cell free culture
720686: qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2
  cell free culture
720687: qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2
  cells
720691: qHTS assay to identify small molecule agonists of the glucocorticoid receptor
  (GR) signaling pathway
720692: qHTS assay to identify small molecule antagonists of the glucocorticoid receptor
  (GR) signaling pathway
720693: qHTS assay to identify small molecule antagonists of the glucocorticoid receptor
  (GR) signaling pathway - cell viability counter screen
720700: Fluorescence-based biochemical high throughput primary assay to identify inhibitors
  of phospholipase C isozymes (PLC-gamma1).
720702: Epi Absorbance-based biochemical primary high throughput screening assay to
  identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2)
720704: Fluorescence-based biochemical high throughput primary assay to identify inhibitors
  of phospholipase C isozymes (PLC-beta3).
720706: HTS for Bacterial rRNA inhibitors Measured in Microorganism-Based System Using
  Plate Reader - 7056-01_Inhibitor_SinglePoint_HTS_Activity
720707: 'qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1):
  primary screen'
720708: 'qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor
  2 (EPAC2): primary screen'
720709: 'qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor
  3 (EPAC1): primary screen'
720711: 'qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2):
  primary screen'
720719: 'qHTS assay to identify small molecule agonists of the glucocorticoid receptor
  (GR) signaling pathway: Summary'
720725: 'qHTS assay to identify small molecule antagonists of the glucocorticoid receptor
  (GR) signaling pathway: Summary'
743012: qHTS assay for identifying genotoxic compounds that show differential cytotoxicity
  against isogenic chicken DT40 cell lines with known DNA damage response pathways
  - wild type cell line
743014: qHTS assay for identifying genotoxic compounds that show differential cytotoxicity
  against isogenic chicken DT40 cell lines with known DNA damage response pathways
  - Rev3 mutant cell line
743015: qHTS assay for identifying genotoxic compounds that show differential cytotoxicity
  against isogenic chicken DT40 cell lines with known DNA damage response pathways
  - Rad54/Ku70 mutant cell line
743033: qHTS assay to identify small molecule antagonists of the androgen  receptor
  (AR) signaling pathway - cell viability counter screen
743035: qHTS assay to identify small molecule antagonists of the androgen receptor
  (AR) signaling pathway
743036: qHTS assay to identify small molecule agonists of the androgen receptor (AR)
  signaling pathway
743040: qHTS assay to identify small molecule agonists of the androgen  receptor (AR)
  signaling pathway using the MDA cell line
743041: qHTS assay to identify small molecule antagonists of the androgen  receptor
  (AR) signaling pathway using the MDA cell line - cell viability counter screen
743042: qHTS assay to identify small molecule antagonists of the androgen  receptor
  (AR) signaling pathway using the MDA cell line
743053: 'qHTS assay to identify small molecule agonists of the androgen receptor (AR)
  signaling pathway: Summary'
743054: 'qHTS assay to identify small molecule antagonists of the androgen receptor
  (AR) signaling pathway using the MDA cell line: Summary'
743063: 'qHTS assay to identify small molecule antagonists of the androgen receptor
  (AR) signaling pathway: Summary'
743064: qHTS assay to identify small molecule antagonists of the thyroid receptor
  (TR) signaling pathway - cell viability counter screen
743065: qHTS assay to identify small molecule antagonists of the thyroid receptor
  (TR) signaling pathway
743066: qHTS assay to identify small molecule agonists of the thyroid receptor (TR)
  signaling pathway
743067: 'qHTS assay to identify small molecule antagonists of the thyroid receptor
  (TR) signaling pathway: Summary'
743069: qHTS assay to identify small molecule antagonists of the estrogen receptor
  alpha (ER-alpha) signaling pathway
743074: qHTS assay to identify small molecule antagonists of the estrogen receptor
  alpha (ER-alpha) signaling pathway - cell viability counter screen
743075: qHTS assay to identify small molecule agonists of the estrogen receptor alpha
  (ER-alpha) signaling pathway
743077: 'qHTS assay to identify small molecule agonists of the estrogen receptor alpha
  (ER-alpha) signaling pathway: Summary'
743078: 'qHTS assay to identify small molecule antagonists of the estrogen receptor
  alpha (ER-alpha) signaling pathway: Summary'
743079: qHTS assay to identify small molecule agonists of the estrogen receptor alpha
  (ER-alpha) signaling pathway using the BG1 cell line
743080: qHTS assay to identify small molecule antagonists of the estrogen receptor
  alpha (ER-alpha) signaling pathway using the BG1 cell line
743081: qHTS assay to identify small molecule antagonists of the estrogen receptor
  alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter
  screen
743083: qHTS assay to identify aromatase inhibitors
743084: qHTS assay to identify aromatase inhibitors - cell viability counter screen
743085: qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor
  (AhR) signaling pathway
743086: qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor
  (AhR) signaling pathway - cell viability counter screen
743091: 'qHTS assay to identify small molecule antagonists of the estrogen receptor
  alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary'
743094: qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated
  receptor gamma (PPARg) signaling pathway
743122: 'qHTS assay to identify small molecule that activate the aryl hydrocarbon
  receptor (AhR) signaling pathway: Summary'
743126: QFRET-based biochemical high throughput primary assay to identify inhibitors
  of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2)
743139: 'qHTS assay to identify aromatase inhibitors: Summary'
743140: 'qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated
  receptor gamma (PPARg) signaling pathway: Summary'
743191: qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated
  receptor gamma (PPARg) signaling pathway
743194: qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated
  receptor gamma (PPARg) signaling pathway - cell viability counter screen
743199: 'qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated
  receptor gamma (PPARg) signaling pathway: Summary'
743202: qHTS assay for small molecule agonists of the antioxidant response element
  (ARE) signaling pathway
743203: qHTS assay for small molecule agonists of the antioxidant response element
  (ARE) signaling pathway - cell viability counter screen
743209: qHTS assay for small molecule activators of the heat shock response signaling
  pathway - cell viability counter screen
743210: qHTS assay for small molecule activators of the heat shock response signaling
  pathway
743211: qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated
  receptor delta (PPARd) signaling pathway - cell viability counter screen
743212: qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated
  receptor delta (PPARd) signaling pathway
743213: qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated
  receptor delta (PPARd) signaling pathway - cell viability counter screen
743215: qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated
  receptor delta (PPARd) signaling pathway
743217: qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor
  (FXR) signaling pathway
743218: qHTS assay to identify small molecule agonists of the farnesoid-X-receptor
  (FXR) signaling pathway - cell viability counter screen
743219: 'qHTS assay for small molecule agonists of the antioxidant response element
  (ARE) signaling pathway: Summary'
743220: qHTS assay to identify small molecule agonists of the farnesoid-X-receptor
  (FXR) signaling pathway
743221: qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor
  (FXR) signaling pathway - cell viability counter screen
743222: qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR)
  signaling pathway
743223: qHTS assay to identify small molecule antagonists of the vitamin D receptor
  (VDR) signaling pathway
743224: qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR)
  signaling pathway - cell viability counter screen
743225: qHTS assay to identify small molecule antagonists of the vitamin D receptor
  (VDR) signaling pathway - cell viability counter screen
743226: 'qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated
  receptor delta (PPARd) signaling pathway: Summary'
743227: 'qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated
  receptor delta (PPARd) signaling pathway: Summary'
743228: 'qHTS assay for small molecule activators of the heat shock response signaling
  pathway: Summary'
743239: 'qHTS assay to identify small molecule agonists of the farnesoid-X-receptor
  (FXR) signaling pathway: Summary'
743240: 'qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor
  (FXR) signaling pathway: Summary'
743241: 'qHTS assay to identify small molecule agonists of the vitamin D receptor
  (VDR) signaling pathway: Summary'
743242: 'qHTS assay to identify small molecule antagonists of the vitamin D receptor
  (VDR) signaling pathway: Summary'
743244: qHTS Assay for Identifying Gametocytocidal Compounds
743255: 'Inhibitors of USP1/UAF1: Primary Screen'
743266: 'qHTS of PTHR Inhibitors: Primary Screen'
743269: TRFRET-based biochemical primary high throughput screening assay to identify
  inhibitors of HIV-1 LEDGF/p75 DNA Integration
743279: 'qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary
  Screen'
743287: Luminescent GLuc Reporter Gene Assay Primary HTS to Identify Small Molecule
  Activator of Glucose Dependent Insulin Secretion Measured in Cell-Based System Using
  Plate Reader - 7055-01_Activator_SinglePoint_HTS_Activity
743288: qHTS assay for cell viability of HEK293 cells
743292: qHTS assay for cell viability of the p53RE-bla HCT-116 cell line
743398: Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity
977611: Experimentally measured binding affinity data (Kd) for protein-ligand complexes
  derived from PDB
1053175: A screen for compounds that inhibit growth of Escherichia coli
1053197: Fluorescence polarization-based biochemical high throughput primary assay
  to identify inhibitors of sialic acid acetylesterase (SIAE)
1117326: nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen
1117329: insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen
1117336: GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen
1117342: HCT116 viability from Cell TiterGlo-screen
1117343: SW480 viability from Cell TiterGlo-screen
1117344: GLP1 secretion from NCI-H716 cells-IC50
1117345: GLP1 secretion from STC-1 cells-IC50
1117346: DLD-1 viability from Cell TiterGlo-screen
1159509: qHTS assay to identify small molecule agonists of the NFkB signaling pathway
1159515: qHTS assay to identify small molecule agonists of the NFkB signaling pathway
  - cell viability counter screen
1159516: qHTS assay to identify small molecule agonists of the endoplasmic reticulum
  stress response signaling pathway
1159517: qHTS assay to identify small molecule agonists of the endoplasmic reticulum
  stress response signaling pathway - cell viability counter screen
1159518: 'qHTS assay to identify small molecule agonists of the NFkB signaling pathway:
  Summary'
1159519: 'qHTS assay to identify small molecule agonists of the endoplasmic reticulum
  stress response signaling pathway: Summary'
1159520: qHTS assay to identify small molecule antagonists of the retinoid-related
  orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen
1159521: 'qHTS assay to identify small molecule antagonists of the retinoid-related
  orphan receptor gamma (ROR-gamma) signaling pathway '
1159523: 'qHTS assay to identify small molecule antagonists of the retinoid-related
  orphan receptor gamma (ROR-gamma) signaling pathway: Summary'
1159524: High Throughput Screening for Foot and Mouth Disease Virus Antivirals
1159525: qHTS assay to identify small molecule agonists of the AP-1 signaling pathway
  - cell viability counter screen
1159526: qHTS assay to identify small molecule agonists of the AP-1 signaling pathway
1159527: qHTS assay to identify small molecule agonists of the RXR signaling pathway
1159528: 'qHTS assay to identify small molecule agonists of the AP-1 signaling pathway:
  Summary'
1159529: qHTS assay to identify small molecule agonists of the RXR signaling pathway
  - cell viability counter screen
1159531: 'qHTS assay to identify small molecule agonists of the RXR signaling pathway:
  Summary'
1159551: qHTS assay to identify small molecule antagonists of the retinoid acid receptor
  (RAR) signaling pathway - cell viability counter screen
1159552: 'qHTS assay to identify small molecule antagonists of the retinoic acid receptor
  (RAR) signaling pathway '
1159553: qHTS assay to identify small molecule agonists of the retinoic acid receptor
  (RAR) signaling pathway
1159555: 'qHTS assay to identify small molecule antagonists of the retinoic acid receptor
  (RAR) signaling pathway: Summary'
